The Interpublic Group of Companies, Inc.IPG reported fourth-quarter 2018 (ended Dec 31, 2018) earnings per share of 89 cents beating the Zacks Consensus Estimate of 81. Earnings also increased on a year-over-year basis.
How Was the Estimate Revision Trend?
Investors should note that the Zacks Consensus Estimate for Interpublic's fourth-quarter 2018 earnings remained stable over the last 90 days.
The company has a decen t earnings history having outperformed the Zacks Consensus Estimate in two of the last four quarters with an average miss of 4.5%.
Revenues Better Than Expected
Interpublic recorded revenues of $2,413.7 million which outperformed the Zacks Consensus Estimate of $2,323 million.
Key Stats to Note : Interpublic reported organic net revenue growth of 7.1% in fourth-quarter 2018. The company experienced an organic growth of 6.3% in the United States and 8% in the international markets in the reported quarter.
Zacks Rank : Currently, Interpublic has a Zacks Rank #3 (Hold) but that could change following the company's earnings report which was just released.
Interpublic Group of Companies, Inc. (The) Price and EPS Surprise
Check back later for our full write up on this Interpublic earnings report later!
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.